C-reactive protein and left atrial appendage velocity are independent determinants of the risk of thrombogenesis in patients with atrial fibrillation

International Journal of Cardiology

Volumn 142, Issue 1, 2010, Pages 22-28

  Cianfrocca, Cinzia ^a   Loricchio, Maria Luisa ^b   Pelliccia, Francesco ^a   Pasceri, Vincenzo ^a   Auriti, Antonio ^a   Bianconi, Leopoldo ^a   Guido, Vincenzo ^a   Rosano, Giuseppe ^c   Mercuro, Giuseppe ^d   Santini, Massimo ^a  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

^b SANDRO PERTINI HOSPITAL   (Italy)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

^d UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Atrial fibrillation; Inflammation; Spontaneous echo contrast; Thrombogenesis; Transesophageal echocardiography

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; D DIMER; ECHO CONTRAST MEDIUM; FIBRINOGEN; THIENOPYRIDINE DERIVATIVE;

ARTERY DIAMETER; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOEMBOLISM; THROMBOGENESIS; THROMBUS;

AGED; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; ATRIAL FUNCTION, LEFT; BLOOD FLOW VELOCITY; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; THROMBOSIS;

EID: 77953327061     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.12.052     Document Type: Article

References (31)

1. Lip G.Y. Does atrial fibrillation confer a hypercoagulable state?. Lancet 346 (1995) 1313-1314
2. Wolf P.A., Abbot R.D., and Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 22 (1991) 983-988
3. Fatkin D., Kelly R.P., and Fenely M.P. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 23 (1994) 961-969
4. Leung D.Y., Black I.W., Cranney G.B., Hopkins A.P., and Walsh W.F. Prognostic implications of left atrial appendage echo contrast in nonvalvular atrial fibrillation. J Am Coll Cardiol 24 (1994) 755-762
5. Zabalgoitia M., Halperin J.L., Pearce L.A., Blackshear J.L., Asinger R.W., and Hart R.G. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. J Am Coll Cardiol 31 (1998) 1622-1626
6. Stroke Prevention in Atrial Fibrillation Investigators. Transesophageal echocardiographic correlates of thromboembolism in high risk patients with nonvalvular atrial fibrillation. The stroke prevention in atrial fibrillation investigators committee on echocardiography. Ann Intern Med 128 (1998) 639-647
7. Roldan V., Marin F., Blann A.D., et al. Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation. Eur Heart J 24 (2003) 1373-1380
8. Conway D.S., Buggins P., Hughes E., and Lip G.Y. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol 43 (2004) 2075-2082
9. Conway D.S., Buggins P., Hughes E., and Lip G.Y. Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. Am Heart J 148 (2004) 462-466
10. Conway D.S., Buggins P., Hughes E., and Lip G.Y. Relation of interleukin-6, C-reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillation. Am J Cardiol 93 (2004) 1368-1373
11. Roldan V., Marin F., Martinez J.G., Garcia-Herola A., Sogorb F., and Lip G.Y. Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation. Am J Cardiol 95 (2005) 881-882
12. Engelmann M.D.M., and JH Svendsen J.H. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 26 (2005) 2083-2092
13. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 (2006) 257-354
14. Hart R.G., Pearce L.A., McBride R., Rothbart R.M., and Asinger R.W. Factors associated with ischaemic stroke during aspirin therapy in atrial fibrillation. Analysis of 2012 participants in the SPAF I-III clinical trials. Stroke 30 (1999) 1223-1229
15. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
16. Schiller N.B., Acquatella H., Ports T.A., et al. Left ventricular volume from paired biplane two-dimensional echocardiography. Circulation 60 (1979) 547-555
17. Seward J.B., Khandheria B.K., Freeman W.K., et al. Multiple transesophageal echocardiography: image orientation, examination technique, anatomic correlations and clinical implications. Mayo Clin Proc 68 (1993) 523-551
18. Sadanandan S., and Sherrid M.V. Clinical and echocardiographic characteristics of left atrial spontaneous echo contrast in sinus rhythm. J Am Coll Cardiol 35 (2000) 1932-1938
19. Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiography in atrial fibrillation: standards for acquisition and interpretation and assessment of inter-observer variability. J Am Soc Echocardiogr 9 (1996) 556-566
20. Illien S., Maroto-Järvinen S., von der Recke G., et al. Atrial fibrillation: relation between clinical risk factors and transesophageal echocardiographic risk factors for thromboembolism. Heart 89 (2003) 165-168
21. Pongratz G., Brandt-Pohlmann M., Henneke K.H., et al. Platelet activation in embolic and preembolic status of patients with nonrheumatic atrial fibrillation. Chest 111 (1997) 929-933
22. Asinger R.W., Koehler J., Pearce L.A., et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast. J Am Soc Echocardiogr 12 (1999) 1088-1096
23. Fatkin D., Herbert E., and Feneley M.P. Hematologic correlates of spontaneous echo contrast in patients with atrial fibrillation and implications for thromboembolic risk. Am J Cardiol 73 (1994) 672-676
24. Black I.W. Spontaneous echo contrast: where there's smoke there's fire. Echocardiography 17 (2000) 373-382
25. Chung M.K., Martin D.O., Sprecher D., et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104 (2001) 2886-2891
26. Boos C.J., Anderson R.A., and Lip G.Y. Is atrial fibrillation an inflammatory disorder?. Eur Heart J 27 (2006) 136-149
27. Roldan V., Marin F., Martinez J.G., Garcia-Hewrola A., Sogorb F., and Lip G.Y. Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation. Am J Cardiol 95 (2005) 881-882
28. Cermak J., Key N.S., Bach R.R., Balla J., Jacob H.S., and Vercellotti G.M. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82 (1993) 513-520
29. Lip G.Y., Lowe G.D., Rumley A., and Dunn F.G. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Br Heart J 73 (1995) 527-533
30. Kamath S., Blann A.D., Chin B.S., et al. A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy. Eur Heart J 23 (2002) 1788-1795
31. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150